MWMark Webster

Mark Webster

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mark Webster has a total of 105 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mechanistic Insights Into How Rewiring and Bifurcation Angle Affect DK‐Crush Stent Deployment

    by Andrea Colombo, Dario Carbonaro, Mingzi Zhang, Claudio Chiastra, Mark Webster, Nigel Jepson, Susann Beier

    Background: Double kissing crush (DKC) is a preferred two‐stent technique for complex coronary bifurcation lesions. Proximal cell rewiring is routinely recommended to reduce technical failure, and DKC is considered effective across various bifurcation angles. However, it remains unclear whether this standard approach is optimal for all patients. Aims: This study investigates the interaction between bifurcation angle and rewiring configuration to identify anatomy‐specific strategies. Methods: Computational modeling of the DKC procedure was used to simulate 12 DKC procedures across three left main bifurcation angles (45°, 70°, and 100°) and four rewiring configurations: proximal−proximal (P−P), proximal−distal (P−D), distal−proximal (D−P), and distal−distal (D−D). Evaluation metrics included stent malapposition, side branch ostium clearance, arterial wall stress, low time‐averaged endothelial shear stress, and high shear rates. Results: DKC performed in wide bifurcations (100°) resulted in worse outcomes, with malapposition reaching 18%, side branch clearance down to 23%, and up to twice the exposure to adverse high shear rates compared to narrower angles. In contrast, intermediate (70°) and narrow (45°) angles generally resulted in more favorable outcomes, though optimal rewiring varied by angle. Proximal strategies, that is, P−P and P−D, were most effective at 70°, while D−D performed best at 45°. No single strategy was consistently superior across all bifurcation angles. Conclusions: DKC outcomes depend on bifurcation angle and can be optimized by tailoring rewiring strategies, challenging the current clinical understanding. These findings support anatomy‐specific procedural planning and intravascular imaging to guide rewiring. This study provides a mechanistic rationale to improve clinical decision‐making and tailor bifurcation interventions.

  • Are Ultrathin Stents Optimal for Bifurcation Lesions? Insights From Computational Modeling of Provisional and DK‐Crush Techniques

    by Andrea Colombo, Dario Carbonaro, Mingzi Zhang, Chi Shen, Ramtin Gharleghi, Ankush Kapoor, Claudio Chiastra, Nigel Jepson, Mark Webster, Susann Beier

    Background: Complex coronary bifurcation lesions remain challenging in percutaneous coronary intervention, with stent design and deployment strategy influencing clinical outcomes. Aims: This study compares the mechanical and hemodynamic performance of the ultrathin‐strut Orsiro and thin‐strut Xience Sierra stent in provisional side branch (PSB) and double kissing crush (DKC) techniques. Methods: We used finite element analyses of bifurcation stent deployment to assess malapposition, ostium clearance, and arterial wall stress for both techniques. Computational fluid dynamics simulations quantified the luminal exposure to low time‐averaged endothelial shear stress (TAESS < 0.4 Pa) and high shear rates (> 1000 s⁻¹). Results: In PSB, Orsiro showed higher malapposition (13.0% vs. 9.6%) but improved SB ostium clearance (77% vs. 64%) and lower low‐TAESS exposure (30.3% vs. 33.6%) compared to Xience. Orsiro also produced higher arterial wall stresses, particularly during kissing balloon inflation. In DKC, differences in malapposition and ostium clearance diminished between stents, though Orsiro retained a hemodynamic advantage with lower low‐TAESS (28.2% vs. 36.3%). Conclusions: Stent design influenced outcomes more strongly in PSB, where anatomical interaction and platform‐specific behavior impacted both structural and hemodynamic results. In DKC, procedural complexity minimized those differences, making the stenting technique the primary performance driver. Nonetheless, Orsiro consistently preserved more favorable flow conditions. These findings highlight the need to match device selection with lesion characteristics in PSB, while in DKC, optimizing procedural steps may have a greater impact than the choice of stent platform.


  • Open Access

    Site‐Specific Antithrombotic Therapy: 24‐Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple‐Drug Eluting Coronary Implant With Two Anticoagulants and Sirolimus

    by Stefan Verheye, Bert Ferdinande, Johan Bennett, Rodolfo Staico, Seif El‐Jack, Pim A. L. Tonino, Alexandre Abizaid, Ian Buysschaert, Douglas Scott, Madhav Menon, et al.

    Background: DESyne BDS Plus represents a novel triple drug therapy (TRx) applied on a coronary stent platform eluting the antiproliferative drug Sirolimus along with two anticoagulants (Rivaroxaban and Argatroban) to reduce the site‐specific thrombotic risk. Aims: To assess the feasibility and safety of this novel device against a contemporary drug‐eluting stent. Methods: This prospective, multicenter randomized (1:1) trial included 202 patients assigned between the device group (DESyne BDS Plus) and the control group (DESyne X2). A subgroup of 58 patients underwent imaging follow‐up at 6 months. The blood pharmacokinetics of Sirolimus and both anticoagulants were assessed in 11 nonrandomized patients. Results: The primary endpoint, target lesion failure (TLF) at discharge or 3‐day postprocedure, whichever occurred first, was 0.0% (0/98) in the device and 5.0% (5/100) in the control group ( p noninferiority < 0.001). The secondary endpoint, late lumen loss at 6 months, was 0.14 mm [90% CI: 0.06; 0.23] and 0.09 mm [90% CI: 0.01; 0.18] in the device ( n = 28) and control group ( n = 27), respectively ( p noninferiority < 0.001). Through 24 months, stent thrombosis (definite/probable) was 0.0% (0/97) versus 1.0% (1/96) in the control, p = 0.497, and TLF was 2.1% (2/97) versus 11.3% (11/97), p = 0.010, respectively. Optical coherence tomography findings including strut coverage and neointimal hyperplasia thickness/volume were similar between the groups. The pharmacokinetic study indicated median maximum blood concentrations (C max ) of Rivaroxaban and Argatroban of 1.38 ng/mL and 1.99 ng/mL, respectively. Conclusions: This is the first clinical evidence of the feasibility of site‐specific antithrombotic therapeutic with two anticoagulants and an antiproliferative mTOR inhibitor.


  • Aorta-Right Atrium Tunnels: A Heart-Blowing Diagnosis

    by S.-H. Kueh, I.P. Grange-Sobe, T. Pasley, M. Webster, C. Occleshaw, C. Kasargod

  • Open Access

    Safety and efficacy of Everolimus‐Eluting bioabsorbable Polymer‐Coated stent in patients with long coronary lesions: The EVOLVE 48 study

    by Dimitrios Karmpaliotis, Robert Stoler, Simon Walsh, Seif El‐Jack, Srinivasa Potluri, Jeffrey Moses, Keith Oldroyd, Adrian Banning, Mark Webster, Azfar Zaman, et al.

    Objectives: The EVOLVE 48 study evaluated the safety and effectiveness of the SYNERGY 48 mm stent for the treatment of long lesions.Background: Clinical evidence supporting the use of very long stents during percutaneous coronary intervention (PCI) is limited. The bioabsorbable polymer SYNERGY stent has shown good long‐term data in a broad population of patients undergoing PCI.Methods: Patients with lesion length >34‐ ≤44 mm and reference vessel diameter (RVD) ≥2.5‐ ≤ 4.0 mm were enrolled in this prospective, multicenter, single‐arm study. The primary endpoint was 12‐month target lesion failure (TLF; composite of target lesion revascularization [TLR], target‐vessel myocardial infarction [TV‐MI], or cardiac death) compared to a prespecified performance goal (PG).Results: A total of 100 patients with mean lesion length of 35.34 ± 7.15 mm (26 patients with lesion length > 40 mm) and mean RVD 2.72 ± 0.44 mm were enrolled. Moderate to severe calcification was present in 30% of the patients and 89% had pre‐TIMI flow grade 3. The rates of technical and clinical procedural success were 100%. One‐year TLF was observed in 4.1% patients compared to a prespecified PG of 19.5% (95% upper confidence bound = 9.1%; p < 0.0001). Cardiac death and TLR were each observed in one patient, and TV‐MI in two patients treated with SYNERGY 48 mm stent. Between the 1‐2‐year timeframe, TV‐MI occurred in one additional patient. None of the patients experienced a definite or probable stent thrombosis through 2 years.Conclusions: PCI of long coronary lesions with the 48 mm SYNERGY stent demonstrated good procedural and clinical outcomes through 2 years, supporting its clinical safety and efficacy.


  • Diagnostic coronary angiography and percutaneous coronary intervention practices in New Zealand: The All New Zealand Acute Coronary Syndrome-Quality Improvement CathPCI registry 3-year study (ANZACS-QI 37)

    by Tom Kai Ming Wang, Chethan Kasargod, Daniel Chan, Sergej Cicovic, Eliazar Dimalapang, Mark Webster, Chris Nunn, Gerry Devlin, Seif El-Jack, Nick Fisher, et al.


  • Proximal to distal Y‐stenting for coronary bifurcation lesions using radial access: A modern bifurcation technique

    by Patricia Ying Jia Ding, Bruce Webber, John Ormiston, Mark Webster

    Proximal to distal Y stenting technique is a modified bifurcation technique based on the original Y stenting technique described over 20 years ago. We use a bench top model to illustrate the steps of the technique, which can provide both provisional and full coverage options, using radial artery access. This technique may be applied in clinical settings on a wide range of bifurcation anatomies with a number of unique advantages.

  • Transcatheter Aortic Valve Implantation In Patients With a Large Aortic Annulus

    by Peter Barr, John Ormiston, Jim Stewart, Parma Nand, Tharumenthiran Ramanathan, Mark Webster


  • Open Access

    Coronary balloon catheter tip damage. A bench study of a clinical problem

    by Trine Ø Barkholt, John A Ormiston, Patricia Ding, Bruce Webber, Ben Ubod, Stephen Waite, Mark Wi Webster

    To confirm clinically that coronary balloon catheter tips may be damaged during bifurcation treatment with side-branch access through the side of a stent. On the bench, we aimed to assess the susceptibility of different balloon designs to damage. We compared catheter tip widths. We tested whether balloon tip flaring can cause stent distortion. We had observed that balloon catheters that failed to cross to a side-branch frequently exhibited tip damage. We examined microscopically for damage 82 balloon tips after clinical side-branch access. In a bench study, the forces required to compress catheter tips 0.5 mm were compared to assess susceptibility to damage. We compared tip widths of balloons of different nominal inflation diameters. We examined stents after side-branch access for distortion. In 42 of 48 (88%) of balloon tips from patients with resistance to or failure to cross through the side of a stent there was tip damage. Even when the balloon crossed without perceptible resistance, tip damage occurred in over half of balloons 18/34 (53%). Some balloon designs were more resistant to damage than others. Tips from balloons of different nominal diameters from the same manufacturer had the same width. Stent distortion caused by damaged balloon tips is improved by kissing balloon post-dilatation. Balloon tip damage is common with crossing between stent struts. This is one cause of failure of a balloon to access a side-branch and a new balloon should be used. If stent distortion is suspected, it should be corrected with kissing balloon post-dilatation.